Grantham, Mayo, Van Otterloo & Co. LLC, (“GMO”), has filed its SEC Form 13F filing detailing its current portfolio of stocks, including the new buys, sold out stakes, additions, and reductions. GMO manages a broad range of products including equity and fixed income strategies across global developed and emerging markets, as well as absolute return strategies, and its clients include endowments, pension funds, public funds, foundations, and cultural institutions.
Baupost’s Seth Klarman: the Fed has broken the stock market [Q4 Letter]
Baupost founder Seth Klarman told investors that the large amounts of stimulus that have been poured into the world's economies are masking the severity of the problems caused by COVID-19. Q4 2020 hedge fund letters, conferences and more In a letter seen by the
The firm was founded in 1977 and holds $104 billion worth of assets under management. GMO has invested $47 billion of its total assets in equities, $42 billion are invested in Asset Allocation, while $9 billion is in Fixed Income, with natural resources holding $2 billion. The firm estimates its absolute return to be about $9 billion.
With regard to investment in Equities, GMO has invested 5% of the $47 billion in Johnson & Johnson (NYSE:JNJ), Software maker Oracle Corporation (NASDAQ:ORCL) accounts for 4.62% of the equities portfolio. GMO seems to like technology and Pharma companies, as Google Inc (NASDAQ:GOOG), Pfizer Inc. (NYSE:PFE), and Microsoft Corporation (NASDAQ:MSFT) wrap up the top five stakes in GMO’s portfolio, with 4.3%, 4.34%, and 4.19% respectively. Overall, GMO’s top ten holdings account for 40.81% of the total equities portfolio.
GMO Q3 New Buys
GMO bought 135 new stocks to add into its gigantic portfolio of assets. Nexen Inc. (NYSE:NXY), which resulted in a portfolio change of 0.1%, while Cencosud SA (NYSE:CNCO)’s acquisition resulted in a portfolio change of 0.06%. GMO also bought stakes in The Shaw Group Inc. (NYSE:SHAW), and Amerigroup Corp. (NYSE:AGP), each representing 0.05% of the equities portfolio.
GMO Q3 Sold-out Stakes
GMO sold-out 73 stocks from its equities portfolio, with the sale of Goodrich Petroleum Corporation (NYSE:GDP) resulting in a 0.1% change in the portfolio. Gen-probe Incorporated (NASDAQ:GPRO)’s sale represented 0.08% change, while Collective Brands Inc. (NYSE:PSS) sale was a 0.07% change. Other sold out stakes include New Oriental Education & Technology Grp (NYSE:EDU), and Cementos Pacasmayo (NYSE:CPAC), with each representing 0.06% change.
GMO also added to 223 and reduced from 255 of its current counters during the quarter.